| 1 |
Rajasuriar R, Wong PL. Disproportionate disability in people with HIV. Lancet HIV 2023;10:e145-6. [PMID: 36774942 DOI: 10.1016/S2352-3018(23)00027-9] [Reference Citation Analysis]
|
| 2 |
INSIGHT Strategic Timing of AntiRetroviral Treatment (START) Study Group. Long-Term Benefits from Early Antiretroviral Therapy Initiation in HIV Infection. NEJM Evidence 2023;2. [DOI: 10.1056/evidoa2200302] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
|
| 3 |
Chiou PY, Tsao WW, Lin KC, Fang YY, Lin KY, Li CL. Risk and Protective Profile of Men Who Have Sex With Men Using Mobile Voluntary HIV Counseling and Testing: Latent Class Analysis. JMIR Public Health Surveill 2023;9:e43394. [PMID: 36795477 DOI: 10.2196/43394] [Reference Citation Analysis]
|
| 4 |
Gandhi RT, Bedimo R, Hoy JF, Landovitz RJ, Smith DM, Eaton EF, Lehmann C, Springer SA, Sax PE, Thompson MA, Benson CA, Buchbinder SP, Del Rio C, Eron JJ Jr, Günthard HF, Molina JM, Jacobsen DM, Saag MS. Antiretroviral Drugs for Treatment and Prevention of HIV Infection in Adults: 2022 Recommendations of the International Antiviral Society-USA Panel. JAMA 2023;329:63-84. [PMID: 36454551 DOI: 10.1001/jama.2022.22246] [Cited by in Crossref: 3] [Article Influence: 3.0] [Reference Citation Analysis]
|
| 5 |
Kostaki EG, Limnaios S, Adamis G, Xylomenos G, Chini M, Mangafas N, Lazanas M, Patrinos S, Metallidis S, Tsachouridou O, Papastamopoulos V, Chatzidimitriou D, Antoniadou A, Papadopoulos A, Protopapas K, Tsiara C, Psichogiou M, Basoulis D, Pilalas D, Paraskeva D, Chrysos G, Paparizos V, Kourkounti S, Sambatakou H, Bolanos V, Sipsas NV, Lada M, Barbounakis E, Kantzilaki E, Panagopoulos P, Petrakis V, Drimis S, Katsarolis I, Lagiou P, Hatzakis A, Magiorkinis G, Skoura L, Paraskevis D. Estimation of the determinants for HIV late presentation using the traditional definition and molecular clock-inferred dates: Evidence that older age, heterosexual risk group and more recent diagnosis are prognostic factors. HIV Med 2022;23:1143-52. [PMID: 36258653 DOI: 10.1111/hiv.13415] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
|
| 6 |
Hamdan S, Smyth E, Murphy ME, Grussing ED, Wei M, Guardado R, Wurcel A. Racial and Ethnic Disparities in HIV Testing in People Who Use Drugs Admitted to a Tertiary Care Hospital. AIDS Patient Care STDS 2022;36:425-30. [PMID: 36301195 DOI: 10.1089/apc.2022.0165] [Reference Citation Analysis]
|
| 7 |
Chiou P, Tsao W, Lin K, Fang Y, Lin K, Li C. Risk and Protective Profile of Men Who Have Sex With Men Using Mobile Voluntary HIV Counseling and Testing: Latent Class Analysis (Preprint).. [DOI: 10.2196/preprints.43394] [Reference Citation Analysis]
|
| 8 |
Wang T, Gu Y, Ran L, Tan X, Peng S. Ways of HIV transmission in China: The effect of age, period, and cohort. Front Public Health 2022;10:941941. [PMID: 36159288 DOI: 10.3389/fpubh.2022.941941] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
|
| 9 |
Marty L, Diawara Y, Rachas A, Grabar S, Costagliola D, Supervie V. Projection of age of individuals living with HIV and time since ART initiation in 2030: estimates for France. J Int AIDS Soc 2022;25 Suppl 4:e25986. [PMID: 36176023 DOI: 10.1002/jia2.25986] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
|
| 10 |
Anderson S, Friedman EE, Eller D, Kerman J, Zhou J, Stanford KA, Ridgway JP, Mcnulty MC. HIV testing in a high prevalence urban area in the US: Identifying missed opportunities two ways. Int J STD AIDS. [DOI: 10.1177/09564624221118484] [Reference Citation Analysis]
|
